Phase IIa Study of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis
Completed · Phase 2 · Has a placebo group
Conditions studied: Multiple Sclerosis
In brief
This study evaluates the use of single agent ublituximab, a novel monoclonal antibody, in participants with relapsing forms of multiple sclerosis.
Key facts
- Study ID
- NCT02738775
- Run by
- TG Therapeutics, Inc.
- People needed
- 49
- Starts
- 2016-05-27
- Expected to finish
- 2018-08-13
- Last updated by the study team
- 2021-07-15
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of relapsing multiple sclerosis
- Active disease
- Greater than or equal to (≥) 2 relapses in prior 2 years or 1 relapse in the year prior to screening and/or ≥1 gadolinium (Gd) enhancing lesion
You may not qualify if…
- Treatment with anti-cluster of differentiation 20 (CD20) monoclonal antibody within the last 12 months
- Treatment with alemtuzumab within the last 12 months
- Pregnant or nursing mothers
Where it is running
- TG Therapeutics Investigational Trial Site — Phoenix, Arizona, United States
- TG Therapeutics Investigational Trial Site — Pasadena, California, United States
- TG Therapeutics Investigational Trial Site — Torrance, California, United States
- TG Therapeutics Investigational Trial Site — Aurora, Colorado, United States
- TG Therapeutics Investigational Trial Site — Fort Collins, Colorado, United States
- TG Therapeutics Investigational Trial Site — Lexington, Kentucky, United States
- TG Therapeutics Investigational Trial Site — Teaneck, New Jersey, United States
- TG Therapeutics Investigational Trial Site — Akron, Ohio, United States
- TG Therapeutics Investigational Trial Site — Columbus, Ohio, United States
- TG Therapeutics Investigational Trial Site — Knoxville, Tennessee, United States
- TG Therapeutics Investigational Trial Site — Round Rock, Texas, United States
- TG Therapeutics Investigational Trial Site — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.